Sequence Note: Size-Heterogeneous Sequences Mark Hot Spots for Asparagine, Serine, and Threonine Insertions in HIV Type 1 Envelope

This publication has 25 references indexed in Scilit:

• Drift from the GPGRAF HIV-1 Envelope V3 Crown Sequence in a North American Inner City
  AIDS Research and Human Retroviruses, 1997
• Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants
  Vaccine, 1997
• Structural comparison of a 15 residue peptide from the V3 loop of HIV‐1_IIIb and an O‐glycosylated analogue
  FEBS Letters, 1996
• Sequence Note: Fluctuating Diversity in the HTLV-IIIB Virus Stock: Implications for Neutralization and Challenge Experiments
  AIDS Research and Human Retroviruses, 1996
• Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop
  Archiv für die gesamte Virusforschung, 1996
• Does the Key to a Successful HIV Type 1 Vaccine Lie among the Envelope Sequences of Infected Individuals?
  AIDS Research and Human Retroviruses, 1995
• The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand
  AIDS, 1995
• Does envelope V3 peptide comprise the principal neutralizing determinant for HIV?
  Vaccine, 1995
• Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
  Proceedings of the National Academy of Sciences, 1989
• Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene
  Cell, 1988